International
Available Domestic
U.S Domestic
Available Domestic
Dragon Pharma
Dragon Pharma SLU-PP-332 1000 mcg - ERR Agonist Tablets
Oral · 1000 mcg/tabs · 100 tabs
In stock · ships within 24h
Out of stock
$110.00
Dragon Pharma SLU-PP-332 1000 mcg is a research compound supplied as 100 tablets of 1000 mcg. It is a pan-agonist of the estrogen-related receptors ERR-alpha, ERR-beta and ERR-gamma, studied in mice as an exercise mimetic, and it is neither a steroid nor a SARM.
Each pack is GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. SLU-PP-332 1000 mcg for sale with U.S. and international shipping.
Shipping
Not available in this combination
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted
Product overview
Dragon Pharma SLU-PP-332 1000 mcg - ERR Pan-Agonist Tablets
Dragon Pharma SLU-PP-332 1000 mcg supplies the ERR pan-agonist SLU-PP-332 as 100 tablets of 1000 mcg. It is a laboratory compound that activates the estrogen-related receptors ERR-alpha, ERR-beta and ERR-gamma, the same receptors that shift muscle towards an oxidative, training-adapted metabolic state. It is not a steroid, not a SARM and not a peptide in the usual sense, although it appears in the same storefront category. SLU-PP-332 for sale from a GMP manufacturer with batch testing and a Certificate of Analysis on file.
- SLU-PP-332 1000 mcg per tablet, 100 tablets per pack
- Pan-agonist of ERR-alpha, ERR-beta and ERR-gamma
- Mouse exposure 0.2 microM in plasma and 0.6 microM in muscle at 6 hours (30 mg/kg)
- GMP-manufactured, HPLC-verified, COA on file per batch
How SLU-PP-332 Works
The estrogen-related receptors regulate gene programmes tied to mitochondrial function and fatty acid oxidation, and activating all three subtypes is what produces the exercise-mimetic effect seen in animal models. That mechanism is closer to the PPAR-delta route used by Cardarine than to anything acting on the androgen receptor, and it is unrelated to the mitochondrial peptide MOTS-c. Because the effect is transcriptional, it builds over weeks rather than hours.
Research Amounts and Handling
There is no human dose and no formal human half-life. In mice, 30 mg per kg intraperitoneally produced 0.2 microM in plasma and 0.6 microM in muscle six hours later, and the 2024 study used 50 mg per kg twice daily for 28 days; those intraperitoneal milligram per kilogram values do not convert into a microgram tablet for humans, and the fact sheet flags that conversion as a mistake. A 2025 publication describes SLU-PP-332 as having no oral bioavailability, so the vendor practice of one 1000 mcg tablet per day is user practice rather than data.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch, which is the only identity check available for a compound with no approved label. No human safety profile exists for SLU-PP-332: cardiovascular complaints such as palpitations are reported anecdotally and the effect on hormones and lipids is unstudied. Its stacking partners in community material are other metabolic compounds such as Cardarine and GW 501516, with no combination data behind any of it.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | SLU-PP-332 |
| Generic Name | SLU-PP-332 (research code, no INN) |
| Manufacturer | Dragon Pharma |
| Dosage | 1000 mcg per tablet |
| Package | 100 tablets per pack |
| Drug Class | ERR pan-agonist research compound (not a steroid or SARM) |
| Administration | Oral, once daily |
| Reference Half-Life | No formal human value; mouse exposure measured at 6 hours |
| Shipping | International and U.S. domestic options |
Stacks
Consult a healthcare professional before any cycle. Doses are common community protocols.
FAQ
Before you ask
Questions, answered
It is SLU-PP-332, a research compound and pan-agonist of the estrogen-related receptors ERR-alpha, ERR-beta and ERR-gamma, supplied as 1000 mcg tablets, 100 per pack. It is not a steroid, not a SARM and not a conventional peptide, though it sits in the peptide category on the storefront. It has no INN, no approved label and no human safety profile.
The estrogen-related receptors control gene programmes for mitochondrial function and fatty acid oxidation, and activating all three subtypes reproduces part of the metabolic adaptation to training in animal models. The effect is transcriptional, so it builds over weeks rather than hours. Mechanistically it sits closer to the PPAR-delta route used by cardarine than to anything acting on the androgen receptor.
There is no human dose. In mice, 30 mg per kg intraperitoneally gave 0.2 microM in plasma and 0.6 microM in muscle at six hours, and the 2024 study used 50 mg per kg twice daily for 28 days. Those figures cannot be converted into a microgram tablet for humans, and a 2025 publication describes the compound as lacking oral bioavailability, so the vendor practice of one 1000 mcg tablet daily is user practice rather than data.
No human safety profile exists, so nothing is quantified. Cardiovascular complaints such as palpitations are reported anecdotally, and the effect of the compound on the hormonal panel and on lipids is unstudied. Because the target receptors also influence tissue signalling beyond muscle, the theoretical concerns around ERR signalling are unresolved in the literature.
Both are metabolic compounds that work through transcription factors rather than receptors for hormones, but they act on different targets: SLU-PP-332 activates the three estrogen-related receptors, while Cardarine activates PPAR-delta. Cardarine carries a rodent carcinogenic signal at 3 mg per kg per day; SLU-PP-332 has no equivalent signal because it has almost no human or chronic data at all.
Yes. The 1000 mcg, 100 tablet pack is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.
No reviews yet
Be the first to share your experience with Dragon Pharma SLU-PP-332 1000 mcg - ERR Agonist Tablets
Log in to write a reviewComplete the cycle
Stack it with
International
Available Domestic
International
International
Available Domestic